Stocktwits on MSN
Theriva™ Biologics licenses SYN-020 to Rasayana Therapeutics for multiple indications
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - ...
Abstract: SYN flooding attack is a common method employed in denial of service (DoS) and distributed denial of service (DDoS). It's hard to maintain the effective defense merely by passive defense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results